21 – 30 of 34
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
(
- Contribution to journal › Article
- 2018
-
Mark
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation : A 22-year follow-up study
(
- Contribution to journal › Article
- 2017
-
Mark
Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)
(
- Contribution to journal › Article
- 2016
-
Mark
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
(
- Contribution to journal › Article
- 2014
-
Mark
Increased levels of UCHL-1 in cerebrospinal fluid from patients with Alzheimer’s disease.
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2010
-
Mark
Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
(
- Contribution to journal › Article
- 2009
-
Mark
Medial Temporal Lobe Atrophy Increases the Specificity of Cerebrospinal Fluid Biomarkers in Alzheimer Disease with Minor Cerebrovascular Changes.
(
- Contribution to journal › Article
-
Mark
Identification of novel candidate protein biomarkers for the post-polio syndrome — Implications for diagnosis, neurodegeneration and neuroinflammation
(
- Contribution to journal › Article
- 2008
-
Mark
Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease
(
- Contribution to journal › Article